Skip to search formSkip to main contentSkip to account menu

timcodar

Known as: (S)-N-Benzyl-p-chloro-alpha-(N-methyl-2-(3,4,5-trimethoxyphenyl)glyoxylamido)-N-(3-(4-pyridyl)-1-(2-(4-pyridyl)ethyl)propyl)hydrocinnamamide 
A drug being studied to make cancer cells less resistant to the effects of chemotherapy.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The authors assessed the ability of the neurophilin compound, timcodar dimesylate, to accelerate the return of epidermal nerve… 
2006
2006
Enantioenriched propargyl mesylates or perfluorobenzoates react with alpha-(N-carbamoyl)alkylcuprates to afford scalemic alpha-(N… 
2006
2006
Abstract  Despite the clinical need, there are no therapeutic compounds available to promote peripheral nerve regeneration. In… 
2004
2004
The asymmetric synthesis of (-)-(R)-pyrrolam A was achieved in three operations from N-Boc pyrrolidine via an alpha-(N-carbamoyl… 
2004
2004
Alpha-(N-carbamoyl)alkylcuprates (RCuCNLi or R2CuLi) react with allylic phosphates to afford homoallylic amines in good chemical… 
2002
2002
The conjugate adducts obtained via coupling of alpha-(N-carbamoyl)alkylcuprates with alpha,beta-ynoates, alpha-allenyl esters, or… 
1996
1996
Kinetics for the hydrolysis of the chromogenic active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl… 
1980
1980
Two previously reported but unidentified phenylburazone degradation products were isolated from a tablet that was stored at 60… 
1970
1970
A synthesis of phosphonic acid analogues of diether L-α-(N,N-dimethyl)cephalins, viz. di-O-tetradecyl, di-O-hexadecyl, and di-O…